Drug Profile
Pemetrexed - Apotex
Alternative Names: Pemetrexed disodium hemipentahydrateLatest Information Update: 06 Jun 2022
Price :
$50
*
At a glance
- Originator Apotex
- Class Antineoplastics; Benzamides; Cancer vaccines; Glutamates; Hypoxanthines; Immunotherapies; Pyrimidines; Pyrroles; Small molecules
- Mechanism of Action Tetrahydrofolate dehydrogenase inhibitors; Thymidylate synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Malignant-mesothelioma; Non-small cell lung cancer
Most Recent Events
- 06 Jun 2022 Janssen Research & Development plans a phase II trial for Hepatitis B in Canada, Czech Republic, France, Italy, Russia, Spain, Taiwan, Turkey and in the UK (NCT05275023)
- 18 Mar 2021 No development reported - Preregistration for Malignant mesothelioma (Inoperable/Unresectable) in USA (Parenteral)
- 18 Mar 2021 No development reported - Preregistration for Non-small cell lung cancer (Adjunctive treatment, Late-stage disease, Metastatic disease) in USA (Parenteral)